APA (7th ed.) Citation

E, S. J., L, R., A, P. Z., J, G., F, R., K, S. N., . . . N, P. Z. (2021). Bayes-based dosing of infliximab in inflammatory bowel diseases: Short-term efficacy. British journal of clinical pharmacology, 87(2), 494. https://doi.org/10.1111/bcp.14410

Chicago Style (17th ed.) Citation

E, Santacana Juncosa, et al. "Bayes-based Dosing of Infliximab in Inflammatory Bowel Diseases: Short-term Efficacy." British Journal of Clinical Pharmacology 87, no. 2 (2021): 494. https://doi.org/10.1111/bcp.14410.

MLA (9th ed.) Citation

E, Santacana Juncosa, et al. "Bayes-based Dosing of Infliximab in Inflammatory Bowel Diseases: Short-term Efficacy." British Journal of Clinical Pharmacology, vol. 87, no. 2, 2021, p. 494, https://doi.org/10.1111/bcp.14410.